Tyto Acquisition Corp, 10% Owner at Prevail Therapeutics Inc. (PRVL), bought 68,569,578 shares at $22.50 ($1.5B) on 2021-01-22, disclosed to the SEC on 2021-01-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.50 | 34,284,789 | $771.4M | 50.0% |
| 2 | $22.50 | 34,284,789 | $771.4M | 50.0% |
| Total | $22.50 avg | 68,569,578 | $1.5B | 100% |